welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)
study id #: NCT00140894
condition: Adenomatous Polyposis Coli
A study to evaluate rofecoxib in the treatment of rectal, colon, or duodenal adenomas in patients with Familial Adenomatous Polyposis.
Drug: MK0966; rofecoxib / Duration of Treatment: 24 weeks
Drug: Comparator: placebo / Duration of Treatment: 24 weeks
start date: March 1, 2003
estimated completion: Not Available
last updated: September 29, 2017
phase of development: Phase 4
size / enrollment: 62
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- Number and average size of rectal polyps
- Safety and tolerability
- Number and average size of duodenal polyps
- Proportions of patients with improved overall colon rating
- Males or females at least 18 years of age with familial adenomatous polyposis.
expertly curated content related to this topic
Surgical Considerations in FAP-related Pouch Surgery: Could We do Better?The ileoanal pouch has become the standa...
How to Manage a Patient with Multiple Adenomatous Polyps: History and Clinical Features, Genetic Testing, Surveillan...Adenomatous polyps are found on screenin...
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive FibromatosisBackground: Desmoid tumors (also kn...
Inherited Cancer Syndromes: Current Clinical ManagementElectronic Book: The second edition of I...
People with Malfunctioning Ileostomy, Colon or Rectum Removal can be Helped with the BCIR Procedurehttps://www.youtube.com/watch?v=sCoTgn32...
Clinical and Genomic Influence of Sulindac on Rectal Mucosa in Familial Adenomatous PolyposisPURPOSE : A study was performed to evalu...
Ileal Pouch Anal Anastomosis: An Overview of Surgery, Recovery, and Achieving Postsurgical ContinenceIleal pouch anal anastomosis (IPAA) is a...